Organosulfur compound protects against memory decline induced by scopolamine through modulation of oxidative stress and Na+/K+ ATPase activity in mice

被引:15
作者
da Silva, Fernanda D. [1 ]
Pinz, Mikaela P. [2 ]
de Oliveira, Renata L. [2 ]
Rodrigues, Karline C. [2 ]
Ianiski, Francine R. [1 ]
Bassaco, Mariana M. [3 ]
Silveira, Claudio C. [3 ]
Jesse, Cristiano R. [4 ]
Roman, Silvane S. [5 ]
Wilhelm, Ethel A. [2 ]
Luchese, Cristiane [2 ]
机构
[1] Ctr Univ Franciscano, Programa Posgrad Nanociencias, Ctr Ciencias Tecnol, BR-97010032 Santa Maria, RS, Brazil
[2] Univ Fed Pelotas, Programa Posgrad Bioquim Bioprospeccao, Lab Pesquisa Farmacol Bioquim LaFarBio, GPN,Ctr Ciencias Quim Farmaceut & Alimentos, Campus Capao Leao, BR-96010900 Pelotas, RS, Brazil
[3] Univ Fed Santa Maria, Ctr Cincias Nat & Exatas, Programa Posgrad Quim, BR-97105900 Santa Maria, RS, Brazil
[4] Univ Fed Pampa, Lab Avaliacoes Farmacol & Toxicol Aplicadas Mol B, LaftamBio Pampa, BR-97650000 Itaqui, RS, Brazil
[5] Univ Reg Integrada, Campus Erechim, BR-99700000 Erechim, RS, Brazil
关键词
Sulfur; Alzheimer's disease; Na+/K+ ATPase activity; Oxidative stress; Divinyl sulfides; ALZHEIMERS-DISEASE; GARLIC OIL; K+-ATPASE; IMPAIRMENT; MECHANISMS; MODEL; INVOLVEMENT; ISCHEMIA; SULFIDE;
D O I
10.1007/s11011-017-0067-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study investigated the possible effect of BMMS in protecting against memory impairment in an Alzheimer's disease model induced by scopolamine in mice. Another objective was to evaluate the involvement of oxidative stress and Na+/K+ ATPase activity in cerebral cortex and hippocampus of mice. Male Swiss mice were divided into four groups: groups I and III received canola oil (10 ml/kg, intragastrically (i.g.)), while groups II and IV received BMMS (10 mg/kg, i.g.). Thirty minutes after treatments, groups III and IV received scopolamine (1 mg/kg, intraperitoneal (i.p.)), while groups I and II received saline (5 ml/kg, i.p.). Behavioral tests were performed thirty minutes after scopolamine or saline injection. Cerebral cortex and hippocampus were removed to determine the thiobarbituric acid reactive species (TBARS) levels, non-protein thiols (NPSH) content, catalase (CAT) and Na+/K+ ATPase activities. The results showed that BMMS pretreatment protected against the reduction in alternation and latency time induced by scopolamine in the Y-maze test and step-down inhibitory avoidance, respectively. In the Barnes maze, the latency to find the escape box and the number of holes visited were attenuated by BMMS. Locomotor and exploratory activities were similar in all groups. BMMS pretreatment protected against the increase in the TBARS levels, NPSH content and CAT activity, as well as the inhibition on the Na+/K+ ATPase activity caused by scopolamine in the cerebral cortex. In the hippocampus, no significant difference was observed. In conclusion, the present study revealed that BMMS protected against the impairment of retrieval of short-term and long-term memories caused by scopolamine in mice. Moreover, antioxidant effect and protection on the Na+/K+ ATPase activity are involved in the effect of compound against memory impairment in AD model induced by scopolamine.
引用
收藏
页码:1819 / 1828
页数:10
相关论文
共 43 条
[1]  
Aebi H, 1984, Methods Enzymol, V105, P121
[2]   Cholinergic influence on memory stages: A study on scopolamine amnesic mice [J].
Agrawal, Rahul ;
Tyagi, Ethika ;
Saxena, Gunjan ;
Nath, Chandishwar .
INDIAN JOURNAL OF PHARMACOLOGY, 2009, 41 (04) :192-196
[3]   Comparative protective action of curcumin, memantine and diclofenac against scopolamine-induced memory dysfunction [J].
Ali, Elham H. A. ;
Arafa, Nadia M. S. .
FITOTERAPIA, 2011, 82 (04) :601-608
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]  
DAWSON GR, 1992, BEHAV PHARMACOL, V3, P285
[6]   Dysregulation of Na+/K+ ATPase by amyloid in APP+PSI transgenic mice -: art. no. 7 [J].
Dickey, CA ;
Gordon, MN ;
Wilcock, DM ;
Herber, DL ;
Freeman, MJ ;
Morgan, D .
BMC NEUROSCIENCE, 2005, 6 (1)
[7]   TISSUE SULFHYDRYL GROUPS [J].
ELLMAN, GL .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1959, 82 (01) :70-77
[8]  
Fiske CH, 1925, J BIOL CHEM, V66, P375
[9]   The cholinergic hypothesis of Alzheimer's disease: a review of progress [J].
Francis, PT ;
Palmer, AM ;
Snape, M ;
Wilcock, GK .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 66 (02) :137-147
[10]   Cholinesterases: New roles in brain function and in Alzheimer's disease [J].
Giacobini, E .
NEUROCHEMICAL RESEARCH, 2003, 28 (3-4) :515-522